The first case of Niemann-Pick disease (NPD) was described in 1914 by the German pediatrician, Albert Niemann (Niemann, 1914). Over the ensuing years, numerous reports of infants with similar clinical manifestations appeared, and in 1927 Ludwig Pick distinguished this disorder from infantile Gaucher disease based on the differential appearance of the bone marrow foam cells (Pick, 1927). The first adults with this disease were described in 1946 (Pflander, 1946; Dusendschon, 1946). By 1925, NPD was known as a storage disease, and the storage material was thought to consist primarily of phospholipid and cholesterol (Bloom, 1925; Sobotka, Epstein, and Lichtenstein, 1930). Later Klenk (1934) identified the phospholipid as sphingomyelin. A deficiency of acid sphingomyelinase (ASM; EC 3.1.4.12) activity was first demonstrated in human tissue samples obtained from NPD patients in 1966 In 1961, Crocker classified NPD into four clinical entities, types A to D (Crocker, 1961). The infantile, neurodegenerative phenotype originally described by Niemann was termed type A. Type B NPD was distinguished from this severe neuronopathic phenotype by the absence of primary neurological involvement, later onset of hepatosplenomegaly, and survival into adulthood. Types C and D, initially thought to be allelic forms of types A and B (based on similar morphological and clinical findings), are now known to be distinct disorders (Pentchev et al., 1984; Carstea et al., 1997). This chapter discusses only types A and B NPD, which are also referred to as ASM-deficient NPD.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bloom W. (1925). Splenomegaly (type Gaucher) and lipoid-histiocytosis (type Niemann), Am J Pathol 1, 595.
Brady RO, Kanfer JN, Mock MB, Fredrickson DS. (1966) The metabolism of sphingo-myelin. II. Evidence of an enzymatic deficiency in Niemann-Pick disease. Proc Natl Acad Sci U S A 55, 366-369.
Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J, Polymeropoulos MH, Sturley SL, Ioannou YA, Higgins ME, Comly M, Cooney A, Brown A, Kaneski CR, Blanchette-Mackie EJ, Dwyer NK, Neufeld EB, Chang TY, Liscum L, Strauss JF 3rd, Ohno K, Zeigler M, Carmi R, Sokol J, Markie D, O'Neill RR, van Diggelen OP, Elleder M, Patterson MC, Brady RO, Vanier MT, Pentchev PG, Tagle DA. (1997) Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis. Science 277, 228-231.
Crocker AC. (1961) The cerebral defect in Tay-Sachs disease and Niemann-Pick disease. J Neurochem 17, 69.
Daloze P, Delvin EE, Glorieux FH, Corman JL, Bettez P, Toussi T. (1977) Replacement therapy for inherited enzyme deficiency: Liver orthotopic transplantation in Niemann-Pick disease type A. Am J Med Genet 1, 229-239.
da Veiga Pereira L, Desnick RJ, Adler DA, Disteche CM, Schuchman EH. (1991) Regional assignment of the human acid sphingomyelinase gene (SMPD1) by PCR analysis of somatic cell hybrids and in situ hybridization to 11p15.1-p15.4. Genomics 9, 229-234.
Dawson PJ, Dawson G. (1982) Adult Niemann-Pick disease with sea-blue histiocytes in the spleen. Hum Pathol 13, 1115-1120.
Dusendschon A. (1946) Deux cas familiaux de maladie de Niemann-Pick chez adulte [Thesis], Geneva, Faculte de Medecine.
Elleder M, Cihula J. (1983) Niemann-Pick disease (variation in the sphingomyelinase-deficient group). Neurovisceral phenotype (A) with an abnormally protracted clinical course and variable expression of neurological symptomatology in three siblings. Eur J Pediatr 140, 323-328.
Ferlinz K, Hurwitz R, Moczall H, Lansmann S, Schuchman EH, Sandhoff K. (1997). Functional characterization of the N-glycosylation sites of human acid sphingomye-linase by site-directed mutagenesis. Eur J Biochem 243, 511-517.
Gal AE, Brady RO, Hibbert SR, Pentchev PG. (1975) A practical chromogenic procedure for the detection of homozygotes and heterozygous carriers of Niemann-Pick disease. N Engl J Med 293, 632-636.
Grunebaum M. (1976) The roentgenographic findings in the acute neuronopathic form of Niemann-Pick disease. Br J Radiol 49, 1018-1022.
Hannun YA. (1997) Sphingolipid second messengers: tumor suppressor lipids. Adv Exp Med Biol 400A, 305-312.
He X, Chen F, Dagan A, Gatt S, Schuchman EH. (2003) A fluorescence-based, high-performance liquid chromatographic assay to determine acid sphingomyelinase activity and diagnose types A and B Niemann-Pick disease. Anal Biochem 314, 116-120.
He X, Miranda SR, Xiong X, Dagan A, Gatt S, Schuchman EH. (1999) Characterization of human acid sphingomyelinase purified from the media of overexpressing Chinese hamster ovary cells. Biochim Biophys Acta 1432, 251-264.
Horinouchi K, Erlich S, Perl DP, Ferlinz K, Bisgaier CL, Sandhoff K, Desnick RJ, Stewart CL, Schuchman EH. (1995) Acid sphingomyelinase deficient mice: A model of types A and B Niemann-Pick disease. Nat Genet 10, 288-293.
Jin HK, Carter JE, Huntley GW, Schuchman EH. (2002) Intracerebral transplantation of bone marrow-derived mesenchymal stem cells into acid sphingomyelinase deficient mice delays the onset of neurological abnormalities and extends their lifespan. J Clin Invest 109, 1183-1191.
Jin HK, Schuchman EH. (2003) Combined bone marrow and intracerebral mesenchymal stem cell transplantation leads to synergistic visceral and neurological improvements in Niemann-Pick disease mice. Mol Ther 26, 775-785.
Kamoshita S, Aron AM, Suzuki K, Suzuki K. (1969) Infantile Niemann-Pick disease. A chemical study with isolation and characterization of membranous cytoplasmic bodies and myelin. Am J Dis Child 117, 379-394.
Klenk E. (1934) Uber die Natur der Phosphatide der Milz bei Niemann-Pickscher Krankheit, Z Physiol Chem 229, 151 (1934).
Kolesnick RN, Kronke M. (1998) Regulation of ceramide and apoptosis. Ann Rev Physiol 60, 643-645.
Lever AM, Ryder JB. (1983) Cor pulmonale in an adult secondary to Niemann-Pick disease. Thorax 38, 873.874.
Li L, Caggana M, Robinowitz, Shabeer J, Desnick RJ, Eng CM. (1997) Prenatal genetics screening in the Ashkenazi Jewish population: A pilot program of multiple option testing for five disorders. Am J Hum Genet 61(Suppl), A24 (1997).
Ludatscher RM, Naveh Y, Auslaender L, Gellei B. (1981) Electron microscopic studies in lipid storage disease. Isr J Med Sci 17, 323-330.
Marathe S, Miranda SR, Devlin C, Johns A, Kuriakose G, Williams KJ, Schuchman EH, Tabas I. (2000) Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: Relationship between brain intra-lysosomal enzyme activity and central nervous system function. Hum Mol Genet 9, 1967-1976.
Miranda SR, Erlich S, Friedrich VL Jr, Gatt S, Schuchman EH. (2000a) Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease. Gene Ther 7, 1768-1776.
Miranda SR, Erlich S, Friedrich VL Jr, Haskins ME, Gatt S, Schuchman EH. (1998) Biochemical, pathological, and clinical response to transplantation of normal bone marrow cells into acid sphingomyelinase deficient mice. Transplantation 65, 884-892.
Miranda SR, He X, Simonaro CM, Gatt S, Dagan A, Desnick RJ, Schuchman EH. (2000b) Infusion of recombinant human acid sphingomyelinase into Niemann-Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology. FASEB J 14, 1988-1995.
Niemann A. (1914) Ein unbekanntes Krankheitsbild, Jahrb Kinderheilkd 79, 1.
Otterbach B, Stoffel W. (1995) Acid sphingomyelinase-deficient mice mimic the neuro-visceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 81, 1053-1061.
Patrick AD, Young E, Kleijer WJ, Niermeijer MF. (1977) Prenatal diagnosis of Niemann-Pick disease type A using chromogenic substrate. Lancet 2, 144.
Pentchev PG, Boothe AD, Kruth HS, Weintroub H, Stivers J, Brady RO. (1984) A genetic storage disorder in BALB/C mice with a metabolic block in esterification of exogenous cholesterol. J Biol Chem 259, 5784-5791.
Pflander U. (1946) La maladie de Niemann-Pick dans le cadre des lipoidoses, Schweiz Med Wochenschr 76.
Pick L. (1927) Uber die lipoidzellige Splenohepatomegalie Typus Niemann-Pick als Stoffwechselerkrankung, Med Klin 23, 1483.
Quintern LE, Schuchman EH, Levran O, Suchi M, Ferlinz K, Reinke H, Sandhoff K, Desnick RJ. (1989) Isolation of cDNA clones encoding human acid sphingomyelinase: Occurrence of alternatively processed transcripts. EMBO J 8, 2469-2473.
Rouser, G., Kritschevsky, G., Yamamoto, A., Knudson, A. G., Jr., Simon, G. (1968) Accumulation of a glycerolphospholipid in classical Niemann-Pick disease. Lipids 3, 287-290.
Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z, Kolesnick R. (1996) Acid sphingomyelinase deficient mice and human lymphoblasts are defective in radiation-induced apoptosis. Cell 86, 189-200.
Scaggiante B, Pineschi A, Sustersich M, Andolina M, Agosti E, Romeo D. (1987) Success-ful therapy of Niemann-Pick disease by implantation of human amniotic membrane. Transplantation 44, 59-61.
Schneider PB, Kennedy EP. (1967) Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. J Lipid Res 8, 202-209.
Schuchman EH, Levran O, Pereira LV, Desnick RJ. (1992) Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1). Genomics 112, 197-205.
Schuchman EH, Levran O, Suchi M, Desnick RJ. (1991a) An MspI polymorphism in the human acid sphingomyelinase gene (SMPD1). Nucleic Acid Res 19, 3160.
Schuchman EH, Suchi M, Takahashi T, Sandhoff K, Desnick RJ. (1991b) Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs. J Biol Chem 266, 8531-8539.
Sikora J, Pavlu-Pereira H, Elleder M, Roelofs H, Wevers RA. (2003) Seven novel acid sphingomyelinase genemutations in Niemann-Pick type A and B patients. Ann Hum Genet 67,63-70.
Simonaro CM, Desnick RJ, McGovern MM, Wasserstein MP, Schuchman EH. (2002) The demographics and distribution of type B Niemann-Pick disease: Novel mutations lead to new genotype/phenotype correlations. Am J Hum Genet 71: 1413-1419.
Simonaro CM, Park JH, Eliyahu E, Shtraizent N, McGovern MM, Schuchman EH. (2006) Imprinting at the SMPD-1 gene: Implications for acid sphingomyelinase-deficient Niemann-Pick disease. Am J Hu. Ge. 78, 79-84.
Sobotka H, Epstein E, Lichtenstein L. (1930) The distribution of lipoid in a case of Niemann-Pick’s disease associated with amaurotic family idiocy, Arch Pathol 10, 677.
Sogawa H, Horino K, Nakamura F, Kudoh T, Oyanagi K, Yamanouchi T, Minami R, Nakao T, Watanabe A, Matsuura Y. (1978) Chronic Niemann-Pick disease with sphingomyelinase deficiency in two brothers with mental retardation. Eur J Pediatr 128, 235-240.
Vanier MT. (1983). Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. Biochim Biophys Acta 750, 178-184.
Vanier MT, Boue J, Dumez Y. (1985) Niemann-Pick disease type B: First-trimester prenatal diagnosis on chorionic villi and biochemical study of a foetus at 12 weeks of development. Clin Genet 28, 348-354.
Vanier MT, Ferlinz K, Rousson R, Duthel S, Louisot P, Sandhoff K, Suzuki K. (1993) Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann-Pick disease type B patients from northern Africa. Hum Genet 92, 325-330.
Vanier MT, Rousson R, Garcia I, Bailloud G, Juge MC, Revol A, Louisot P. (1985) Biochemical studies in Niemann-Pick disease. III. In vitro and in vivo assays of sphingomyelin degradation in cultured skin fibroblasts and amniotic fluid cells for the diagnosis of the various forms of the disease. Clin Genet 27, 20-32.
Victor S, Coulter JB, Besley GT, Ellis I, Desnick RJ, Schuchman EH, Vellodi A. (2003) Niemann-Pick disease type B: 16 year follow-up after allogenic bone marrow trans-plantation. J Inherit Met Dis 26, 775-785.
Wan Q and Schuchman EH. (1995) A novel polymorphism in the human acid sphingo-myelinase gene due to size variation of the signal peptide region. Biochim Biophys Acta 1270, 207-210.
Weitz G, Driessen M, Brouwer-Kelder EM, Sandhoff K, Barranger JA, Tager JM, Schram AW. (1985) Soluble sphingomyelinase from human urine as antigen for obtaining anti-sphingomyelinase antibodies. Biochim Biophys Acta 838, 92-97.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Schuchmann, E.H., McGovern, M., Simonaro, C.M., Wasserstein, M.P., Desnick, R.J. (2007). Acid Sphingomyelinase-Deficient Niemann–Pick Disease. In: Lysosomal Storage Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-70909-3_17
Download citation
DOI: https://doi.org/10.1007/978-0-387-70909-3_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-70908-6
Online ISBN: 978-0-387-70909-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)